Kiniksa Pharma (NASDAQ: KNSA) reported first quarter EPS of $0.11, $0.09 better than the analyst estimate of $0.02. Revenue for the quarter came in at $137.7M versus the consensus estimate of $131.07M.
Kiniksa Pharma’s stock price closed at $21.47. It is up 9.54% in the last 3 months and up 32.21% in the last 12 months.
Kiniksa Pharma saw positive EPS revisions and negative EPS revisions in the last 90 days. See Kiniksa Pharma’s stock price’s past reactions to earnings here.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.